Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 Jan;1(1):111–114. doi: 10.1128/cdli.1.1.111-114.1994

Elevated Candida antigen titers are associated with neutrophil dysfunction after injury.

J F Sweeney 1, A S Rosemurgy 1, S Wei 1, J Y Djeu 1
PMCID: PMC368206  PMID: 7496911

Abstract

This study was undertaken to determine if impaired neutrophil (polymorphonuclear leukocytes [PMNL]) function is associated with an elevated Candida antigen titer after injury. PMNL from eight severely injured adults with Candida antigen titers of > or = 1:4 (titer positive) were evaluated for the ability to inhibit growth of Candida albicans in vitro by using a [3H]glucose incorporation assay. PMNL from eight severely injured adults with titers of < 1:4 (titer negative) and from eight healthy volunteers were studied for comparison. PMNL from the titer-positive patients had suppressed ability to inhibit C. albicans growth compared with PMNL from titer-negative patients and healthy volunteers. In vitro, PMNL function against C. albicans could be augmented significantly by cytokines. Granulocyte macrophage-colony-stimulating factor was most potent at augmenting function, followed by interleukin-8 and gamma interferon. Injured patients with elevated candida antigen titers have impaired PMNL function against C. albicans, and this function can be restored by cytokines.

Full text

PDF
111

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashman R. B., Papadimitriou J. M., Ott A. K., Warmington J. R. Antigens and immune responses in Candida albicans infection. Immunol Cell Biol. 1990 Feb;68(Pt 1):1–13. doi: 10.1038/icb.1990.1. [DOI] [PubMed] [Google Scholar]
  2. Bach M. C., Sahyoun A., Adler J. L., Schlesinger R. M., Breman J., Madras P., P'eng F., Monaco A. P. High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression. Transplant Proc. 1973 Mar;5(1):549–553. [PubMed] [Google Scholar]
  3. Baker S. P., O'Neill B. The injury severity score: an update. J Trauma. 1976 Nov;16(11):882–885. doi: 10.1097/00005373-197611000-00006. [DOI] [PubMed] [Google Scholar]
  4. Blanchard D. K., Michelini-Norris M. B., Djeu J. Y. Production of granulocyte-macrophage colony-stimulating factor by large granular lymphocytes stimulated with Candida albicans: role in activation of human neutrophil function. Blood. 1991 May 15;77(10):2259–2265. [PubMed] [Google Scholar]
  5. Bougnoux M. E., Hill C., Moissenet D., Feuilhade de Chauvin M., Bonnay M., Vicens-Sprauel I., Pietri F., McNeil M., Kaufman L., Dupouy-Camet J. Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol. 1990 May;28(5):905–909. doi: 10.1128/jcm.28.5.905-909.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cho S. Y., Choi H. Y. Opportunistic fungal infection among cancer patients. A ten-year autopsy study. Am J Clin Pathol. 1979 Oct;72(4):617–621. doi: 10.1093/ajcp/72.4.617. [DOI] [PubMed] [Google Scholar]
  7. Diamond R. D., Clark R. A., Haudenschild C. C. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J Clin Invest. 1980 Nov;66(5):908–917. doi: 10.1172/JCI109958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Djeu J. Y., Blanchard D. K., Halkias D., Friedman H. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol. 1986 Nov 1;137(9):2980–2984. [PubMed] [Google Scholar]
  9. Djeu J. Y., Matsushima K., Oppenheim J. J., Shiotsuki K., Blanchard D. K. Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol. 1990 Mar 15;144(6):2205–2210. [PubMed] [Google Scholar]
  10. Djeu J. Y., Parapanissios A., Halkias D., Friedman H. A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods. 1986 Aug 21;92(1):73–77. doi: 10.1016/0022-1759(86)90505-3. [DOI] [PubMed] [Google Scholar]
  11. Gold J. W., Wong B., Bernard E. M., Kiehn T. E., Armstrong D. Serum arabinitol concentrations and arabinitol/creatinine ratios in invasive candidiasis. J Infect Dis. 1983 Mar;147(3):504–513. doi: 10.1093/infdis/147.3.504. [DOI] [PubMed] [Google Scholar]
  12. Jones J. M. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev. 1990 Jan;3(1):32–45. doi: 10.1128/cmr.3.1.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kahn F. W., Jones J. M. Latex agglutination tests for detection of Candida antigens in sera of patients with invasive candidiasis. J Infect Dis. 1986 Mar;153(3):579–585. doi: 10.1093/infdis/153.3.579. [DOI] [PubMed] [Google Scholar]
  14. Mildvan D., Mathur U., Enlow R. W., Romain P. L., Winchester R. J., Colp C., Singman H., Adelsberg B. R., Spigland I. Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med. 1982 Jun;96(6 Pt 1):700–704. doi: 10.7326/0003-4819-96-6-700. [DOI] [PubMed] [Google Scholar]
  15. Walsh T. J., Hathorn J. W., Sobel J. D., Merz W. G., Sanchez V., Maret S. M., Buckley H. R., Pfaller M. A., Schaufele R., Sliva C. Detection of circulating candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med. 1991 Apr 11;324(15):1026–1031. doi: 10.1056/NEJM199104113241504. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES